A citation-based method for searching scientific literature

Oliver Gruber, Antonella Chadha Santuccione, Helmut Aach. Front Psychiatry 2014
Times Cited: 30







List of co-cited articles
87 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


The positive and negative syndrome scale (PANSS) for schizophrenia.
S R Kay, A Fiszbein, L A Opler. Schizophr Bull 1987
23

Relationship between Glutamate Dysfunction and Symptoms and Cognitive Function in Psychosis.
Kate Merritt, Philip McGuire, Alice Egerton. Front Psychiatry 2013
61
13

Elevated prefrontal cortex γ-aminobutyric acid and glutamate-glutamine levels in schizophrenia measured in vivo with proton magnetic resonance spectroscopy.
Lawrence S Kegeles, Xiangling Mao, Arielle D Stanford, Ragy Girgis, Najate Ojeil, Xiaoyan Xu, Roberto Gil, Mark Slifstein, Anissa Abi-Dargham, Sarah H Lisanby,[...]. Arch Gen Psychiatry 2012
235
13

Mice with reduced NMDA receptor expression display behaviors related to schizophrenia.
A R Mohn, R R Gainetdinov, M G Caron, B H Koller. Cell 1999
791
13

Rethinking schizophrenia.
Thomas R Insel. Nature 2010
13

Glutamate in schizophrenia: a focused review and meta-analysis of ¹H-MRS studies.
Anouk Marsman, Martijn P van den Heuvel, Dennis W J Klomp, René S Kahn, Peter R Luijten, Hilleke E Hulshoff Pol. Schizophr Bull 2013
297
13


Glutamatergic abnormalities in schizophrenia: a review of proton MRS findings.
Eline M P Poels, Lawrence S Kegeles, Joshua T Kantrowitz, Daniel C Javitt, Jeffrey A Lieberman, Anissa Abi-Dargham, Ragy R Girgis. Schizophr Res 2014
110
10

Circuit-based framework for understanding neurotransmitter and risk gene interactions in schizophrenia.
John E Lisman, Joseph T Coyle, Robert W Green, Daniel C Javitt, Francine M Benes, Stephan Heckers, Anthony A Grace. Trends Neurosci 2008
717
10

Recent advances in the phencyclidine model of schizophrenia.
D C Javitt, S R Zukin. Am J Psychiatry 1991
10

GABA and glutamate in schizophrenia: a 7 T ¹H-MRS study.
Anouk Marsman, René C W Mandl, Dennis W J Klomp, Marc M Bohlken, Vincent O Boer, Anna Andreychenko, Wiepke Cahn, René S Kahn, Peter R Luijten, Hilleke E Hulshoff Pol. Neuroimage Clin 2014
102
10

Ketamine effects on brain GABA and glutamate levels with 1H-MRS: relationship to ketamine-induced psychopathology.
J M Stone, C Dietrich, R Edden, M A Mehta, S De Simoni, L J Reed, J H Krystal, D Nutt, G J Barker. Mol Psychiatry 2012
188
10

Imaging glutamate in schizophrenia: review of findings and implications for drug discovery.
E M P Poels, L S Kegeles, J T Kantrowitz, M Slifstein, D C Javitt, J A Lieberman, A Abi-Dargham, R R Girgis. Mol Psychiatry 2014
142
10


Negative symptoms in schizophrenia: avolition and Occam's razor.
George Foussias, Gary Remington. Schizophr Bull 2010
373
10


Brain connectivity abnormalities predating the onset of psychosis: correlation with the effect of medication.
André Schmidt, Renata Smieskova, Jacqueline Aston, Andor Simon, Paul Allen, Paolo Fusar-Poli, Philip K McGuire, Anita Riecher-Rössler, Klaas E Stephan, Stefan Borgwardt. JAMA Psychiatry 2013
70
6

Near-infrared spectroscopy in schizophrenia: a possible biomarker for predicting clinical outcome and treatment response.
Shinsuke Koike, Yukika Nishimura, Ryu Takizawa, Noriaki Yahata, Kiyoto Kasai. Front Psychiatry 2013
39
6

The psychosis high-risk state: a comprehensive state-of-the-art review.
Paolo Fusar-Poli, Stefan Borgwardt, Andreas Bechdolf, Jean Addington, Anita Riecher-Rössler, Frauke Schultze-Lutter, Matcheri Keshavan, Stephen Wood, Stephan Ruhrmann, Larry J Seidman,[...]. JAMA Psychiatry 2013
881
6

Pharmacological characterizations of memantine-induced disruption of prepulse inhibition of the acoustic startle response in mice: involvement of dopamine D2 and 5-HT2A receptors.
Kota Nakaya, Osamu Nakagawasai, Yuichiro Arai, Hiroshi Onogi, Atsushi Sato, Fukie Niijima, Koichi Tan-No, Takeshi Tadano. Behav Brain Res 2011
18
11

Ketamine-induced exacerbation of psychotic symptoms and cognitive impairment in neuroleptic-free schizophrenics.
A K Malhotra, D A Pinals, C M Adler, I Elman, A Clifton, D Pickar, A Breier. Neuropsychopharmacology 1997
495
6

Alterations in the serotonin system in schizophrenia: a systematic review and meta-analysis of postmortem and molecular imaging studies.
Sudhakar Selvaraj, Danilo Arnone, Alessandra Cappai, Oliver Howes. Neurosci Biobehav Rev 2014
119
6

SSR180711, a novel selective alpha7 nicotinic receptor partial agonist: (II) efficacy in experimental models predictive of activity against cognitive symptoms of schizophrenia.
Philippe Pichat, Olivier E Bergis, Jean-Paul Terranova, Alexandre Urani, Christine Duarte, Vincent Santucci, Christiane Gueudet, Carole Voltz, Régis Steinberg, Jeanne Stemmelin,[...]. Neuropsychopharmacology 2007
223
6

Double-blind, placebo-controlled, crossover trial of glycine adjuvant therapy for treatment-resistant schizophrenia.
U Heresco-Levy, D C Javitt, M Ermilov, C Mordel, A Horowitz, D Kelly. Br J Psychiatry 1996
199
6

Glutamate modulators as potential therapeutic drugs in schizophrenia and affective disorders.
Kenji Hashimoto, Berend Malchow, Peter Falkai, Andrea Schmitt. Eur Arch Psychiatry Clin Neurosci 2013
162
6


N-Acetyl cysteine reverses social isolation rearing induced changes in cortico-striatal monoamines in rats.
Marisa Möller, Jan L Du Preez, Francois P Viljoen, Michael Berk, Brian H Harvey. Metab Brain Dis 2013
30
6

The environment and schizophrenia.
Jim van Os, Gunter Kenis, Bart P F Rutten. Nature 2010
884
6



Neonatal intrahippocampal immune challenge alters dopamine modulation of prefrontal cortical interneurons in adult rats.
Carlos Feleder, Kuei Yuan Tseng, Gwendolyn G Calhoon, Patricio O'Donnell. Biol Psychiatry 2010
44
6




Stress-restress evokes sustained iNOS activity and altered GABA levels and NMDA receptors in rat hippocampus.
Brian H Harvey, Frasia Oosthuizen, Linda Brand, Gregers Wegener, Dan J Stein. Psychopharmacology (Berl) 2004
117
6

Involvement of the NMDA receptor, NO-cyclic GMP and nuclear factor K-beta in an animal model of repeated trauma.
Brian H Harvey, Tanya Bothma, Ané Nel, Gregers Wegener, Dan J Stein. Hum Psychopharmacol 2005
31
6

Glutamate neurocircuitry: theoretical underpinnings in schizophrenia.
Thomas L Schwartz, Shilpa Sachdeva, Stephen M Stahl. Front Pharmacol 2012
103
6

A double-blind, randomized study of minocycline for the treatment of negative and cognitive symptoms in early-phase schizophrenia.
Yechiel Levkovitz, Shlomo Mendlovich, Sharon Riwkes, Yoram Braw, Hana Levkovitch-Verbin, Gilad Gal, Shmuel Fennig, Ilan Treves, Shmuel Kron. J Clin Psychiatry 2010
273
6

Meta-analysis of cytokine alterations in schizophrenia: clinical status and antipsychotic effects.
Brian J Miller, Peter Buckley, Wesley Seabolt, Andrew Mellor, Brian Kirkpatrick. Biol Psychiatry 2011
6

Effect of paliperidone and risperidone on extracellular glutamate in the prefrontal cortex of rats exposed to prenatal immune activation or MK-801.
Nicole L Roenker, Gary Gudelsky, Rebecca Ahlbrand, Stefanie L Bronson, Joseph R Kern, Heather Waterman, Neil M Richtand. Neurosci Lett 2011
42
6

Stress is critical for LPS-induced activation of microglia and damage in the rat hippocampus.
A M Espinosa-Oliva, R M de Pablos, R F Villarán, S Argüelles, J L Venero, A Machado, J Cano. Neurobiol Aging 2011
104
6




Ketamine and peripheral inflammation.
Marc De Kock, Sebastien Loix, Patricia Lavand'homme. CNS Neurosci Ther 2013
103
6


Redox dysregulation, neurodevelopment, and schizophrenia.
Kim Q Do, Jan H Cabungcal, Anita Frank, Pascal Steullet, Michel Cuenod. Curr Opin Neurobiol 2009
271
6

Social isolation rearing induces mitochondrial, immunological, neurochemical and behavioural deficits in rats, and is reversed by clozapine or N-acetyl cysteine.
Marisa Möller, Jan L Du Preez, Francois P Viljoen, Michael Berk, Robin Emsley, Brian H Harvey. Brain Behav Immun 2013
116
6




Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.